Funding Rounds
HEPHAISTOS-Pharma

HEPHAISTOS-Pharma Seed (2024, $4M)

HEPHAISTOS-Pharma

Immunotherapies developer for cancer patient.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Seed

Raised Amount: $4.60M

Investors